DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sedation During Bronchoscopy:Dexmedetomidine vs Alfentanil

Information source: Saint-Joseph University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Bronchoscopy; Conscious Sedation

Intervention: xylocain (Drug); Alfentanil (Drug); Dexmedetomidine (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Saint-Joseph University

Official(s) and/or principal investigator(s):
Moussa A Riachy, MD, FCCP, Principal Investigator, Affiliation: Saint-Joseph University


The purpose of this study is to find the best sedation necessary for patients undergoing bronchoscopy. Patients are randomized to three different regimes of sedation during bronchoscopy were studied:

1. - Group standard/control: local anesthesia only(C)

2. - Group alfentanil + local anesthesia(A)

3. - Group dexmedetomidine + local anesthesia(D) The primary endpoint is the bronchoscopy

score. Secondary endpoints are: Level of sedation and tolerance bronchoscopy examination. Measured parameters on the safety of examination are: the lowest saturation, needs to supplemental oxygen, amnesia , choking sensation or chest pain and if the patient is ready or not to undertake bronchoscopy second time in his life if necessary. Endtidal CO2, Respiratory rate, Blood pressure, Heart rate, level of oxygen are collected every 5 minutes before, during and after the bronchoscopy.

Clinical Details

Official title: Success of Sedation During Bronchoscopy: Comparison of the Effects of Dexmedetomidine, Alfentanil and Local Anesthesia

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Bronchoscopy score

Secondary outcome: Level of sedation for bronchoscopy

Detailed description: BACKGROUND: 1. Problem: The endoscopy of the tracheobronchial tree by endoscopy is an act very common in the daily activity of pulmonologists. The indications for bronchoscopy are multiple and include infectious causes, tumor, systemic disease, foreign bodies and other indications. It can be diagnostic or therapeutic purposes. Bronchoscopy is an invasive but rarely, however, induced severe complications (respiratory failure, hemodynamic collapse, massive bleeding ...). However, tolerance to the examination varies significantly between patients [1-3]. Different signs and symptoms include desaturation, chest pain, choking sensation and cough. These effects are likely to alter patient comfort during the procedure and the quality of it. To further improve the tolerance operators have resorted to various techniques. A first step in improving the comfort is a good local anesthesia using spray or swab intra nasal base and lidocaine anesthesia of the airway (trachea, carina and bronchi) during the examination. The second step involves the use of intravenous sedation [1, 3-14]. 2. Background: Until now, there is no standardized protocol for the best product and the best dose to use for sedation of patients. Several studies have been done comparing different drug or drug combination in the benzodiazepine family, ketamine or morphine with varying results and not leading in most cases to allow conclusions to establish clear guidelines regarding the use or no sedation plus local anesthesia and sedation dose of this [1, 3, 5, 8, 15]. Especially, for fear of adverse effects of sedation on respiratory function, many pulmonologists far are a little hesitant about the administration of sedatives during bronchoscopy. Dexmedetomidine is a new molecule sedation which is approved for its sedative effect while holding a revival meeting described as "awake sedation." [12, 16-22] DESCRIPTION: The aim of this randomized controlled trial was to evaluate the feasibility and safety of three different regimes of sedation during bronchoscopy:

- Group standard / control (local anesthesia only): (C)

- Group alfentanil (+ local anesthesia): (A)

- Group dexmedetomidine (+ local anesthesia): (D)

The primary endpoint is: 1. / Feasibility / tolerance of bronchoscopy by the "score bronchoscopy" which includes:

- The movement of the vocal cords (4 levels)

- Cough (4 levels)

- Movement members (4 levels)

Secondary objectives: 2. / level sedation for bronchoscopy:

- Level of sedation achieved according to the objective using: Nursing Instrument

for the Communication of Sedation (NICS) (7 levels).

- Dose of midazolam necessary complementary in each group. Midazolam to give to the

judgment of the operator (if necessary) is predetermined speed (1 mg each minute) to the level of sedation (-1) "Level of sedation achieved according to the objective using: Nursing Instrument for the communication of Sedation (NICS)". 3. / Tolerance examination:

- During the procedure

- At the end of the procedure

- After 1 hour of the end of the examination


Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Both.


Inclusion Criteria:

- All patients admitted for diagnostic flexible bronchoscopy in the endoscopy

department Exclusion Criteria:

- Bronchoscopy outside the endoscopy unit

- Tracheal stenosis

- SpO2 <90% in the open air

- Bradycardia <55 per minute

- Atrioventricular block

- Heart failure known (EF <40%)

- Alcoholism (> 5 drinks per week)

Locations and Contacts

Hotel Dieu de France Hospital, Beirut, Lebanon
Additional Information

Starting date: February 2013
Last updated: November 22, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017